Melanoma patients vaccinated with peptide-pulsed DCs

Melanoma patients were vaccinated with peptide-pulsed DC (MAGE-A3, gp100, NA17 and tyrosinase), while other patients were vaccinated with peptides +/s adjuvant or viral vectors (ALVAC canarypox virus containing a MAGE-A3 minigene). There was a correlation between tumor regression and detection of anti-MAGE-3.A1 CTL responses.

created over 16 years ago (4 March 2009)    last modified over 13 years ago (28 September 2011)   [ RDF ]   [ RelFinder ]